Canale M, Virga A, Angeli D, Fonzi E, Gnetti L, Dubini A, Tedaldi G, Urbini M, Bocchialini G, Petracci E, Verlicchi A, Cravero P, Citarella F, Bennati C, Andrikou K, Delmonte A, Crinò L, Carbognani P, Ulivi P, Ampollini L

Lung Cancer: Targets and Therapy 2025, 16:85-96

Published Date: 28 June 2025

Clinical Trial Report

Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma

Du H, Song X, Wu F

Lung Cancer: Targets and Therapy 2025, 16:73-83

Published Date: 9 June 2025

Original Research

Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells

Polonio-Alcalá E, Ausellé-Bosch S, Riesco-Llach G, Novales P, Feliu L, Planas M, Ciurana J, Puig T

Lung Cancer: Targets and Therapy 2025, 16:57-72

Published Date: 27 May 2025

Commentary

LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)

Luo FX, Arter Z, Ou SI, Nagasaka M

Lung Cancer: Targets and Therapy 2025, 16:51-55

Published Date: 25 April 2025

Original Research

Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study

Dao TV, Dinh VL, Doan TV, Phuong TL

Lung Cancer: Targets and Therapy 2025, 16:39-49

Published Date: 21 April 2025

Original Research

Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer

Chen CY, Ko HW, Hu PW, Chang CY, Chen CY, Chang SC, Chiu YC, Wei YF

Lung Cancer: Targets and Therapy 2025, 16:25-37

Published Date: 12 April 2025

Original Research

Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival

Canale M, Urbini M, Petracci E, Angeli D, Tedaldi G, Priano I, Cravero P, Flospergher M, Andrikou K, Bennati C, Tassinari D, Dubini A, Rossi G, Panzacchi R, Valli M, Bronte G, Crinò L, Delmonte A, Ulivi P

Lung Cancer: Targets and Therapy 2025, 16:11-23

Published Date: 20 February 2025

Original Research

Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC

Arter ZL, Shieh K, Nagasaka M, Ou SHI

Lung Cancer: Targets and Therapy 2025, 16:1-9

Published Date: 19 February 2025